Home
Resources
Diseases
Training
SYSVAC
About
Registry
E-learning courses
News
Events
Network
Vision and Mission
Steering Committee
Map
Meetings
Join us
Home
Resources
Resources
Selected
France
COVID-19
French (FR)
2021
Clear all
Type of publications
NITAG documentation
(16)
Topics
Regions
Europe
(16)
Countries
France
(16)
Belgium
(13)
Burkina Faso
(1)
Canada
(4)
Senegal
(2)
Diseases
COVID-19
(16)
Influenza
(1)
Publication date
2021
(16)
2023
(2)
2022
(8)
2020
(4)
Target population
Risk group
(1)
Available to download in languages
French (FR)
(16)
16 results found
2021
∙
Haute Autorité de Santé
HAS opinion relating to the launch of the 2021/2022 vaccination campaign against seasonal influenza in France in the northern hemisphere and in Mayotte in the context of the 'Covid-19 epidemic - May 12, 2021.
2021
∙
Haute Autorité de Santé
HAS recommendation on Place of Moderna's Spikevax® mRNA vaccine in 12 to 17 year olds - July 28, 2021
2021
∙
Haute Autorité de Santé
HAS recommendation on the place of a booster with the COMIRNATY mRNA vaccine
2021
∙
Haute Autorité de Santé
HAS recommendation on Vaccination strategy against Covid-19 - Place of the COMIRNATY® mRNA vaccine in 12-15 year olds - 3 June, 2021
2021
∙
Haute Autorité de Santé
HAS Sars-Cov-2 vaccination strategy - Role of socio-economic and professional factors in the risk of infection and severe forms of Covid-19 and updating of recommendations - 1 July 2021
2021
∙
Haut Conseil de la santé publique
HAS statement on AstraZeneca vaccine in response to new vaccine safety concerns - 8 April, 2021
2021
∙
Haut Conseil de la santé publique
HAS statement relating to the possibility of carrying out a vaccination schedule with two mRNA vaccines of different specialties in exceptional situations - 29 April, 2021
2021
∙
Haute Autorité de Santé
HAS vaccination strategy against Covid-19 - Place of the COMIRNATY® mRNA vaccine in 12-15 year olds - 03 June, 2021
2021
∙
Haute Autorité de Santé, Commission Technique des Vaccinations
Modification of the vaccine schedule against SARS-CoV-2 in the new epidemic context
2021
∙
Haut Conseil de la santé publique
Potential impact of the circulation of SARS-CoV-2 variants on the COVID - 19 strategy - 9 April, 2021
Home
Resources
Diseases
Training
SYSVAC
News
Events
Network
Sign in / Register